Eculizumab in atypical hemolytic-uremic syndrome

N Engl J Med. 2013 Oct 3;369(14):1378-9. doi: 10.1056/NEJMc1308826.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Complement C5 / antagonists & inhibitors*
  • Female
  • Hemolytic-Uremic Syndrome / drug therapy*
  • Humans
  • Male
  • Thrombotic Microangiopathies / prevention & control*

Substances

  • Antibodies, Monoclonal, Humanized
  • Complement C5